Report from the Melanoma Independent Board First Melanoma MIB Conference, 21–22 October 2013

The Melanoma Independent Board (MIB) held its first conference from 21 to 22 October, 2013, in Rome, Italy. Like the MIB itself, the conference brought together specialists from all aspects of cancer care: doctors, patient associations, journalists, and representatives from local government, hospita...

Descripción completa

Detalles Bibliográficos
Autores principales: Testori, A, Ascierto, P, Chiarion Sileni, V, De Lorenzo, F, Pelicci, PG, Rossi, CR
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2014
Materias:
Conference Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096026/
https://www.ncbi.nlm.nih.gov/pubmed/25075214
http://dx.doi.org/10.3332/ecancer.2014.440
Descripción
Sumario:The Melanoma Independent Board (MIB) held its first conference from 21 to 22 October, 2013, in Rome, Italy. Like the MIB itself, the conference brought together specialists from all aspects of cancer care: doctors, patient associations, journalists, and representatives from local government, hospitals, and pharma to encourage an interdisciplinary discussion on the future of melanoma. It was hoped that the conference would be an opportunity for all participants to see and understand each other’s points of view. In memoriam of melanoma pioneer Natalie Cascinelli, the conference focussed on innovation and sustainability as well as the latest drug developments.

Ejemplares similares